Prognosis did not significantly differ (P = 0.71; Fig. S2) between the groups delineated based on PD‐L1 positivity on tumor and non‐malignant microenvironment immune cells, based on the presently used cut‐off values (e.g., 40% of the latter). Here, CD274 is linked to neoplasm.